FOXO1 modulates osteoblast differentiation

Bone

Volumn 48, Issue 5, 2011, Pages 1043-1051

  Siqueira, Michelle F ^a   Flowers, Stephen ^b   Bhattacharya, Rupa ^c   Faibish, Dan ^d   Behl, Yugal ^d   Kotton, Darrell N ^e   Gerstenfeld, Lou ^e   Moran, Elizabeth ^b   Graves, Dana T ^a  

^a WESTERN UNIVERSITY   (Canada)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BOSTON UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone differentiation; Forkhead; Mineralizing matrix; Osteoblast; RUNX2transcription factor

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; COLLAGENASE 3; CYCLINE; DNA; MESSENGER RNA; OSTEOCALCIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MINERALIZATION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; RNA INTERFERENCE; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; IN SITU NICK-END LABELING; LENTIVIRUS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 79954626201     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.01.019     Document Type: Article

References (29)

1. Gerstenfeld L., Cullininane D., Barnes G., Graves D., Einhorn T. Fracture healing as a post-natal developmental process: molecular, spatial, adn temporal aspects of its regulation. J Cell Biochem 2003, 88:873-884.
2. Ai-Aql Z.S., Alagl A.S., Graves D.T., Gerstenfeld L.C., Einhorn T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008, 87:107-118.
3. Yamaguchi A., Komori T., Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 2000, 21:393-411.
4. Senta H., Park H., Bergeron E., Drevelle O., Fong D., Leblanc E., et al. Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations. Cytokine Growth Factor Rev 2009, 20:213-222.
5. Wang E.A., Israel D.I., Kelly S., Luxenberg D.P. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 1993, 9:57-71.
6. Jonason J.H., Xiao G., Zhang M., Xing L., Chen D. Post-translational regulation of Runx2 in bone and cartilage. J Dent Res 2009, 88:693-703.
7. Ji C., Casinghino S., Chang D., Chen Y., Javed A., Ito Y., et al. CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem 1998, 69:353-363.
8. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010, 339:189-195.
9. van der Vos K.E., Coffer P.J. FOXO-binding partners: it takes two to tango. Oncogene 2008, 27:2289-2299.
10. Behl Y., Siqueira M., Ortiz J., Li J., Desta T., Faibish D., et al. Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen. J Immunol 2008, 181:8711-8718.
11. Osyczka A.M., Diefenderfer D.L., Bhargave G., Leboy P.S. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 2004, 176:109-119.
12. Hatta M., Daitoku H., Matsuzaki H., Deyama Y., Yoshimura Y., Suzuki K., et al. Regulation of alkaline phosphatase promoter activity by forkhead transcription factor FKHR. Int J Mol Med 2002, 9:147-152.
13. Rached M.T., Kode A., Xu L., Yoshikawa Y., Paik J.H., Depinho R.A., et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab 2010, 11:147-160.
14. Ambrogini E., Almeida M., Martin-Millan M., Paik J.H., Depinho R.A., Han L., et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab 2010, 11:136-146.
15. Hong D., Chen H.X., Yu H.Q., Liang Y., Wang C., Lian Q.Q., et al. Morphological and proteomic analysis of early stage of osteoblast differentiation in osteoblastic progenitor cells. Exp Cell Res 2010, 316:2291-2300.
16. Wiznerowicz M., Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003, 77:8957-8961.
17. Mostoslavsky G., Kotton D.N., Fabian A.J., Gray J.T., Lee J.S., Mulligan R.C. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther 2005, 11:932-940.
18. Lee E.R. Proteolytic enzymes in skeletal development: histochemical methods adapted to the study of matrix lysis during the transformation of a "cartilage model" into bone. Front Biosci 2006, 11:2538-2553.
19. Kanazawa I., Yamaguchi T., Yano S., Yamauchi M., Yamamoto M., Sugimoto T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 2007, 8:51.
20. Raskopf E., Vogt A., Sauerbruch T., Schmitz V. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. J Hepatol 2008, 49:977-984.
21. Zhang Y., Hassan M.Q., Xie R.L., Hawse J.R., Spelsberg T.C., Montecino M., et al. Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats). J Biol Chem 2009, 284:3125-3135.
22. Barbara A., Delannoy P., Denis B.G., Marie P.J. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism 2004, 53:532-537.
23. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983, 96:191-198.
24. Nakae J., Kitamura T., Kitamura Y., Bigss W.H., Arden K., Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003, 4:119-129.
25. Gerin I., Bommer G.T., Lidell M.E., Cederberg A., Enerback S., Macdougald O.A. On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake. J Biol Chem 2009, 284:10755-10763.
26. Takada I., Kouzmenko A.P., Kato S. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 2009, 5:442-447.
27. Rached M.T., Kode A., Silva B.C., Jung D.Y., Gray S., Ong H., et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 2010, 120:357-368.
28. Behl Y., Krothapalli P., Desta T., Dipiazza A., Roy S., Graves D.T. Diabetes-enhanced tumor necrosis factor-{alpha} production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 2008, 172:1411-1418.
29. Huang H., Tindall D.J. Dynamic FoxO transcription factors. J Cell Sci 2007, 120:2479-2487.